APA (7th ed.) Citation

Ugurel, S., Schadendorf, D., Figl, A., Rittgen, W., & Delorme, S. (2006). In vitro drug sensitivity predicts response and survival after individualized sensitivity-directed chemotherapy in metastatic melanoma: A multicenter phase II trial of the Dermatologic Cooperative Oncology Group. Clinical cancer research, 12(18), . https://doi.org/10.1158/1078-0432.CCR-05-2763

Chicago Style (17th ed.) Citation

Ugurel, Selma, Dirk Schadendorf, Adina Figl, Werner Rittgen, and Stefan Delorme. "In Vitro Drug Sensitivity Predicts Response and Survival After Individualized Sensitivity-directed Chemotherapy in Metastatic Melanoma: A Multicenter Phase II Trial of the Dermatologic Cooperative Oncology Group." Clinical Cancer Research 12, no. 18 (2006). https://doi.org/10.1158/1078-0432.CCR-05-2763.

MLA (9th ed.) Citation

Ugurel, Selma, et al. "In Vitro Drug Sensitivity Predicts Response and Survival After Individualized Sensitivity-directed Chemotherapy in Metastatic Melanoma: A Multicenter Phase II Trial of the Dermatologic Cooperative Oncology Group." Clinical Cancer Research, vol. 12, no. 18, 2006, https://doi.org/10.1158/1078-0432.CCR-05-2763.